Associated Papers
Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q.
Adema V et al.
Ebiomedicine, 2022
35617825 (PubMed )
Supplement: mmc3.xlsx › Suppl_Table_3
Tumor-derived CK1α mutations enhance MDMX inhibition of p53.
Liu X et al.
Oncogene, 2020
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents.
Merlevede J et al.
Nature Communications, 2016
26908133 (PubMed )
Supplement: ncomms10767-s2.xls › Feuille1
CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q).
Bello E et al.
British Journal of Haematology, 2015
Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.
Schneider RK et al.
Cancer Cell, 2014
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.
Graubert TA et al.
Nature Genetics, 2011
22158538 (PubMed )
Supplement: NIHMS337712-supplement-1.pdf
Select a paper to view details